As of May 22
| -0.07 / -2.44%|
The 3 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 2.50. The median estimate represents a +42.86% increase from the last price of 2.80.
The current consensus among 3 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.